Newsfeeds - Spark Newswire

1 minute read

Psychedelic Stock Gainers And Losers From November 23, 2022

Today, 2:24 AM

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 54.13% at $0.13 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 8.56%…

ATAI

2 minute read

Cathie Wood Increases Stake In 4 Stocks By Over 1,000% – Plus 4 New Holdings For Ark

By Robert Kuczmarski

Today, 2:24 AM

Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.

ADBE

2 minute read

Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday

By Lisa Levin

Today, 2:24 AM

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session.

AMBA

2 minute read

atai Life Sciences And Massachusetts General Hospital Announce Initiation Of Clinical Study Investigating Neuroplasticity Biomarkers In Treatment-Resistant Depression Patients Undergoing Ketamine Treatment

By Benzinga Newsdesk

Today, 2:24 AM

atai Life Sciences N.V. (NASDAQ:ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced it has initiated a clinical study

ATAI

4 minute read

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup

By Lara Goldstein

Today, 2:24 AM

Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

ATAI

2 minute read

Atai Life Sciences’ Q3 2022 Financials & Business Update, ‘Strong Capability To Execute’

By Lara Goldstein

Today, 2:24 AM

Clinical-stage psychedelics company atai Life Sciences N.V. (NASDAQ: ATAI) reported its financial results for the quarter ended September 30, 2022 and shared business developments.

ATAI